Other
Clover Provides Updates on Business and R&D Pipeline Development
Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global commercial-stage biotechnology company committed to unleashing the power of innovative vaccines to save lives and improve health around the world, today provided updates on business and R&D pipeline development.
Henlius Holds its 1st Overseas Scientific Advisory Board Meeting of 2023
Henlius successfully held its first Overseas Scientific Advisory Board (SAB) meeting of 2023 in California, United States.
Dyadic Announced an MoU with Bangladesh’s State-Owned Pharmaceutical Company to Facilitate Biopharmaceutical Research and Biomanufacturing Capacity
JUPITER, Fla. and DHAKA, Bangladesh, June 21, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein bioproduction and unmet clinical needs for effective, affordable and accessible biopharmaceutical products for human and animal health, today announced that it has entered into a Memorandum of Understanding (“MoU”) with Essential Drugs Company Limited (EDCL), the state owned pharmaceutical company under the Ministry of Health and Family Welfare of Bangladesh to facilitate biopharmaceutical research, pre-clinical development, cGMP production, clinical trials, regulatory and other relevant areas of interest in Bangladesh.
After Singapore, US approves sale of lab-grown meat
Two companies, Upside Foods and Good Meat, have announced that they have received the final approval from the US Department of Agriculture to sell lab-grown meat, clearing the path for the first-ever sales of the product in the United States.
AbbVie Says BeiGene’s Flagship Blood Cancer Drug Infringes Imbruvica Patent
BeiGene Ltd (NASDAQ: BGNE) says it is aware that Pharmacyclics LLC has filed a complaint alleging that BeiGene's blood cancer therapy Brukinsa (zanubrutinib) infringes a Pharmacyclics patent issued on June 13, 2023. Pharmacyclics is an AbbVie Inc (NYSE: ABBV) company.
Chinese Drugmakers March Into Africa Seeking New Business Foothold
Chinese pharmaceutical companies are gearing up a foray into Africa with multibillion-yuan investments in local drugmaking facilities, lured by the unmet health-care needs of the world's fastest growing and most underserved continent.
Xi Jinping meets Bill Gates in China, calls him ‘an old friend’
BEIJING, June 16 (Reuters) - Chinese President Xi Jinping called Bill Gates "an old friend" and said he hoped they could cooperate in a way that would benefit both China and the United States, in Xi's first meeting with a foreign entrepreneur in years.
Sanyou Milestones | Super Trillion Common Light Chain Antibody Discovery Platform Launched
SHANGHAI, June 11, 2023 /PRNewswire/ -- On June 12th, 2023 local time, Sanyou Biopharmaceuticals Co., Ltd. officially announced the launch of "Sanyou Super Trillion Common Light Chain Antibody Discovery Platform" (the "platform").
Shineco Subsidiary Registered as a Member of Pharmaceutical Chamber of Commerce
Shineco Life Science Research Co., Ltd., was registered as a member of the All-China Federation of Industry and Commerce Medical & Pharmaceutical Chamber of Commerce (the “Pharmaceutical Chamber of Commerce”), and Ms. Jennifer Zhan, CEO of Shineco, became a member of the Pharmaceutical Chamber of Commerce.
Lab monkey prices soar in U.S. after China cuts off exports
Source: KAORI YOSHIDA, Nikkei Asia staff writer “NEW YORK — Prices of laboratory monkeys in the U.S. have jumped around 15-fold from pre-COVID levels, with ... Read more
